Cinryze 42227-0081
Generic: Human C1-Esterase Inhibitor
Product NDC
42227-0081- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Plasma Derivative
- Marketing Start
- December 1, 2008
- Listing Expires
- December 31, 2026
- Application
- BLA125267
Active Ingredients
| Ingredient | Strength |
|---|---|
| Human C1-Esterase Inhibitor | 500 [iU]/5mL |
Drug Class
Decreased Vascular Permeability [PE]Human C1 Esterase Inhibitor [EPC]Kallikrein Inhibitors [MoA]
Packaging Options(1)
5 mL in 1 VIAL, SINGLE-USE (42227-081-01)